semaglutide impulse control – GLP-1 medications like semaglutide and

However, fat was reaccumulated upon the discontinuation of treatment [3]

NAD+ decline with age

(iii) Enhancing Causal Inference Quality in the Absence of RCTs: Priority should be given to strategies such as target trial emulation, propensity score methods, negative controls, and sensitivity analyses

& Spechler, S

Given the results from recent studies, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend that patients with T2D and clinical cardiovascular disease (CVD) with inadequate glucose control despite treatment with metformin should receive an SGLT2 inhibitor or GLP-1 receptor agonist